Outset Medical (Nasdaq: OM) announced today that the FDA says it addressed all issues cited in a 2023 warning letter.
Outset Medical, Inc. (Nasdaq: OM) ("Outset"), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity ...
Inc. (NASDAQ:OM), a medical technology company focused on innovating dialysis treatment, has resolved all concerns raised in a Warning Letter from the U.S. Food and Drug Administration (FDA) dating ...
EST Outset Medical (OM) files $100M mixed securities shelfMaximize Your Portfolio with Data Driven Insights:Leverage the power of ...
BTIG analyst Maria Thibault revised the price target for Outset Medical (TASE:PMCN) Inc. (NASDAQ:OM) to $3.00, a decrease from the previous $4.00, while continuing to recommend a Buy rating for the ...
Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of ...
Outset Medical, Inc. has successfully closed a private placement, issuing 863,340 shares of Series A Non-Voting Convertible Preferred Stock and entered into a $100 million credit agreement with ...
Outset Medical, Inc. SAN JOSE, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to ...
Outset Medical has announced a $169 million private placement financing and a new debt facility of up to $125 million, aiming to retire prior debt and bolster its financial position. This ...
Outset Medical, Inc. (OM) stock price is 0.85 and Outset Medical, Inc. (OM) 10-day simple moving average is 0.81. Outset Medical, Inc. (OM) stock price is 0.85 and Outset Medical, Inc. (OM ...
SAN JOSE, CA – Outset Medical (TASE:PMCN), Inc., a company specializing in electromedical and electrotherapeutic apparatus with a market capitalization of $44 million, announced on Thursday a ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...